Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-802-8 | CAS number: 68608-82-2 A complex combination of hydrocarbons obtained by the alkylation of benzene with ethene. It consists primarily of ethylbiphenyls, diethylbenzenes with lesser amounts of butylbenzenes and polyethylbenzenes.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral OECD 422 in rats
14, 28 and 90 day inhalation studies in rats
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 20 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- acceptable
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LOAEC
- 20 mg/m³
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- acceptable
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- acceptable
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- limited
Additional information
Inhalation studies:
In the 14 day inhalation study (10 exposure days), the highest dose level tested (83 mg/m3) was considered to be the NOAEC. At this dose, there was a small drop in terminal body weight (5%), but it was not significant. There were no clinical signs of toxicity nor any gross or microscopic signs of toxicity. Some small fluctuations in organ weights occurred in the high dose group, but these were considered related to the small drop in body weight and not an adverse effect. There was no assessment of clinical chemistry or hematology in this study.
In the 1 month inhalation study (exposure 6h/d, 5d/wk), the findings were largely consistent with those observed in the 14 day inhalation study. The highest dose in this study was approximately 500 mg/m3 and this dose produced a number of clinical signs of toxicity (alopecia, red staining around the eyes and nose, behavioural changes) as well as effects on body weight and organ weights. Body weights were depressed in the high dose group (males and females) and there were some associated increases in organ weights, for example the liver (absolute and relative weight). This affect on liver weight was considered to be treatment related and may be an adaptive response to treatment rather than an adverse effect since there were no related histopathological findings that accompanied the change in liver weight. Other changes in organ weights were attributed to the decrease in body weight in the high dose animals. Hematology and clinical chemistry did not produce any consistent findings (some significant increases and decreases observed, but no clear dose response), with the exception of female plasma cholinesterase. This was depressed (significantly) in all female dose groups, with the level in the high dose group being approximately 1/3 that of the control. Plasma cholinesterase has been associated with liver damage, and in the high dose females there were also indications of liver damage based on clinical chemistry parameters such as SGPT, creatinine and globulin levels which were all significantly increased compared to control. However, there were no such changes in these parameters at the lower dose levels, nor was there any pathology, or organ weight data to indicate liver toxicity at the middle and lower doses. Therefore, the significance of this finding is unclear. It is limited only to the females and does not appear to be associated with any other changes and whilst liver damage can cause changes in plasma cholinesterase, it is understood (at least in humans) that a number of other causes exist, for example such as stress and injuries such as bone breakage. Based on the lack of other findings in the mid and low doses and the unclear significance of the plasma cholinesterase changes, it can be argued that the NOAEC for this study is actually the mid dose of approximately 95 mg/m3.
In the 3 month inhalation study (exposure 6h/d, 5d/wk), the findings were very consistent with those identified in the previous studies, but the decreases in body weight and organ weight changes occurred to some extent at all doses in at least one sex. Body weights were decreased in the males at the high dose only (400 mg/m3), but in the females at all doses (20, 100 and 400 mg/m3). It is of note that in the mid dose (100 mg/m3), the decrease in body weight only became significant during the 4th week, which is somewhat consistent with the lack of effects on body weight at a similar dose in the 1 month study. In the high dose group in both males and females, there were various increases in clinical chemistry parameters that are consistent with the liver being a target organ for toxicity (increased SGPT, creatinine, globulin). There were no gross or microscopic pathological changes indicative of liver toxicity, although there was again an increase in the males (all doses) and females (high dose only) in the absolute and relative liver weights. Kidney weights (absolute) in the high dose males and relative kidney weights in the high dose males and all female dose groups were increased relative to control. This, however, could be an artifact of effects on body weight since there was no pathology associated with the changes in organ weight. Female plasma cholinesterase was significantly decreased in a dose related manner in the mid and high dose groups, and a non significant decrease in the low group. Again, the significance of this finding is unclear, particularly since there was no effect on the erythrocyte cholinesterase levels. In the high dose males and females, there also appeared to be evidence of a mild anemia; however, the etiology of this is unclear since there was no supporting pathology, or evidence of increased red blood cell destruction. Taking all the findings together, it appears that the liver is a target organ, but effects observed may be adaptive rather than adverse (at least at the mid and low doses). The remaining effects on body weight effects could be related to stress (respiratory and sensory irritancy was observed in all studies following exposure, but generally limited to the highest dose) and decreased food consumption/efficiency, although unfortunately there was no recording of food consumption to confirm this. Thus, whilst there appears to be evidence of systemic toxicity it does not appear to be 'specific' and the effects observed at the lowest dose in this study (20 mg/m3) (female body weight decrease, and increased absolute and relative liver weights) could thus be considered as 'general signs of toxicity'.
An important consideration to be taken into account when assessing the inhalation studies is that they were all performed using whole body exposure. The test atmospheres were generated using an aerosol to give the required doses. However, the vapour pressure of this substance is so low that this material will have a tendency to settle out of the air and deposit on the surfaces of the cage and the animals fur. This will result in a combination of oral and inhalation exposure since the test material would be consumed during preening, the end result being potentially higher systemic exposures than if one were to simply convert the air concentration to a systemic dose.
Also of note in both these inhalation studies are the clinical observations in the high dose groups (510 mg/m3 and 400 mg/m3 in the 1 and 3 month studies, respectively). These clinical signs indicate some irritancy (allopecia, irritation of the eyes etc.), but also indicate that the animals were somewhat distressed by the exposure, and may have had some evidence of a central nervous depression (lack of cleaning of the fur, some behavioural changes, general malaise). This information might suggest that this substance is also producing some acute CNS depression such as seen with other hydrocarbon solvents like diethyl benzene, ethyl benzene, etc. It appears that these effects do not persist after exposure and recovery occurs. Thus, the effects appear to be transient in nature.
Oral toxicity studies:
In the OECD 422 study, doses of 80 and 320 mg/kg bw produced evidence of systemic toxicity presenting as body weight and organ weight changes. There were no significant findings in the FOB, clinical chemistry or hematology (with the exception of a decrease in eosinophil levels in the high and mid dose group). There were no test article-related macroscopic findings at the scheduled necropsies. Mean absolute and relative kidney weights in the 80 and 320 mg/kg/day group males and mean absolute and relative liver weights in the 320 mg/kg/day group males and females were increased. Also in the 320 mg/kg/day group, mean absolute and relative thyroid gland weights were increased in the females, and mean absolute and relative thymus weights were decreased in males and females. No test article- related effects on organ weights were observed in the 20 mg/kg/day group males or females. Test article- related increased incidences and severity of mineralization, multifocal deposits or irregular basophilic material were noted in the kidneys in the 320 mg/kg/day group males, correlating to increased kidney weights. Hepatocellular hypertrophy was observed in the livers of these males, corresponding to increased liver weights. Follicular cell hypertrophy was observed in the thyroid gland in the 320 mg/kg/day group males and females. This finding correlated to increased thyroid gland weights in these animals and is possibly linked to the increase in liver size at this dose. Atrophy of the thymus was observed in three females in the 320 mg/kg/day group, corresponding to decreased thymus weight in these females. No test article- related microscopic findings were observed in the 20 or 80 mg/kg/day group males and females.The NOAEL for systemic toxicity was considered to 20 mg/kg/day based on decrements in body weight gains and/or food consumption and changes in organ weights in the 80 and 320 mg/kg/day groups and microscopic findings in the 320 mg/kg/day group.
Considering the consistency between the main findings of the inhalation and oral studies, it appears that there are minimal differences in dosing via the two routes and bioavailability can be considered to be similar.
Justification for classification or non-classification
No classification for chronic toxicity or target organ toxicity is proposed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.